Literature DB >> 30123691

Standard strategies for diagnosis and treatment of patients with newly diagnosed Parkinson disease: BRAZIL.

Francisco Cardoso1.   

Abstract

Entities:  

Year:  2013        PMID： 30123691      PMCID： PMC6097006          DOI： 10.1212/01.CPJ.0000437019.37541.a2

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN： 2163-0402


× No keyword cloud information.
  13 in total

1.  Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.

Authors:  Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang
Journal:  Arch Neurol       Date:  2010-05

Review 2.  The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the motor symptoms of Parkinson's disease.

Authors:  Susan H Fox; Regina Katzenschlager; Shen-Yang Lim; Bernard Ravina; Klaus Seppi; Miguel Coelho; Werner Poewe; Olivier Rascol; Christopher G Goetz; Cristina Sampaio
Journal:  Mov Disord       Date:  2011-10       Impact factor: 10.338

3.  Levodopa and the progression of Parkinson's disease.

Authors:  Stanley Fahn; David Oakes; Ira Shoulson; Karl Kieburtz; Alice Rudolph; Anthony Lang; C Warren Olanow; Caroline Tanner; Kenneth Marek
Journal:  N Engl J Med       Date:  2004-12-09       Impact factor: 91.245

Review 4.  EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease.

Authors:  A Berardelli; G K Wenning; A Antonini; D Berg; B R Bloem; V Bonifati; D Brooks; D J Burn; C Colosimo; A Fanciulli; J Ferreira; T Gasser; F Grandas; P Kanovsky; V Kostic; J Kulisevsky; W Oertel; W Poewe; J-P Reese; M Relja; E Ruzicka; A Schrag; K Seppi; P Taba; M Vidailhet
Journal:  Eur J Neurol       Date:  2013-01       Impact factor: 6.089

5.  Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa.

Authors:  R J Hardie; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

6.  Practice Parameter: diagnosis and prognosis of new onset Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  O Suchowersky; S Reich; J Perlmutter; T Zesiewicz; G Gronseth; W J Weiner
Journal:  Neurology       Date:  2006-04-11       Impact factor: 9.910

Review 7.  The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease.

Authors:  Klaus Seppi; Daniel Weintraub; Miguel Coelho; Santiago Perez-Lloret; Susan H Fox; Regina Katzenschlager; Eva-Maria Hametner; Werner Poewe; Olivier Rascol; Christopher G Goetz; Cristina Sampaio
Journal:  Mov Disord       Date:  2011-10       Impact factor: 10.338

8.  A double-blind, delayed-start trial of rasagiline in Parkinson's disease.

Authors:  C Warren Olanow; Olivier Rascol; Robert Hauser; Paul D Feigin; Joseph Jankovic; Anthony Lang; William Langston; Eldad Melamed; Werner Poewe; Fabrizio Stocchi; Eduardo Tolosa
Journal:  N Engl J Med       Date:  2009-09-24       Impact factor: 91.245

9.  Parkinsonism and Parkinson's disease in the elderly: a community-based survey in Brazil (the Bambuí study).

Authors:  Maira Tonidandel Barbosa; Paulo Caramelli; Débora Palma Maia; Mauro César Quintão Cunningham; Henrique Leonardo Guerra; Maria Fernanda Lima-Costa; Francisco Cardoso
Journal:  Mov Disord       Date:  2006-06       Impact factor: 10.338

Review 10.  Meta-analysis of early nonmotor features and risk factors for Parkinson disease.

Authors:  Alastair J Noyce; Jonathan P Bestwick; Laura Silveira-Moriyama; Christopher H Hawkes; Gavin Giovannoni; Andrew J Lees; Anette Schrag
Journal:  Ann Neurol       Date:  2012-10-15       Impact factor: 10.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.